Last 12 months
Inside the activity.
0 purchase rows · 32 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 11 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 12, 2023 Filed Sep 13, 2023 21:24 UTC |
Rossmiller Gregory ScottSVP & CAO
|
SaleCommon Stock | 13,236 | $14.03 | $185,701.08 |
DisclosureSEC source: 0001209191-23-049309 · doc4.xml · nonDerivative · entry 2 Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 189,437 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.9974 to $14.1173, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F3 · ownership.direct: The reported sale of 13,236 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2022. Read SEC document |
| September 12, 2023 Filed Sep 13, 2023 21:22 UTC |
Llorca JesusEVP & CFO
|
SaleCommon Stock | 15,872 | $14.03 | $222,684.16 |
DisclosureSEC source: 0001209191-23-049308 · doc4.xml · nonDerivative · entry 2 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 389,422 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.9985 to $14.1221, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F3 · ownership.direct: The reported sale of 15,872 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022. Read SEC document |
| September 11, 2023 Filed Sep 13, 2023 21:24 UTC |
Rossmiller Gregory ScottSVP & CAO
|
SaleCommon Stock | 602 | $14.00 | $8,428.00 |
DisclosureSEC source: 0001209191-23-049309 · doc4.xml · nonDerivative · entry 1 Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 202,673 F1 · ownership.direct: The reported sale of 602 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2022. Read SEC document |
| September 11, 2023 Filed Sep 13, 2023 21:22 UTC |
Llorca JesusEVP & CFO
|
SaleCommon Stock | 899 | $14.00 | $12,586.00 |
DisclosureSEC source: 0001209191-23-049308 · doc4.xml · nonDerivative · entry 1 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 405,294 F1 · ownership.direct: The reported sale of 899 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022. Read SEC document |
| September 07, 2023 Filed Sep 7, 2023 20:53 UTC |
Llorca JesusEVP & CFO
|
SaleCommon Stock | 1,770 | $13.08 | $23,151.60 |
DisclosureSEC source: 0001209191-23-048655 · doc4.xml · nonDerivative · entry 3 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 406,193 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F6 · ownership.direct: The reported sale of 1,770 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022. Read SEC document |
| September 06, 2023 Filed Sep 7, 2023 20:53 UTC |
Llorca JesusEVP & CFO
|
SaleCommon Stock | 2,543 | $13.02 | $33,109.86 |
DisclosureSEC source: 0001209191-23-048655 · doc4.xml · nonDerivative · entry 2 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 407,963 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.115, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F4 · ownership.direct: The reported sale of 2,543 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022. Read SEC document |
| September 05, 2023 Filed Sep 7, 2023 20:53 UTC |
Llorca JesusEVP & CFO
|
SaleCommon Stock | 5,687 | $13.01 | $73,987.87 |
DisclosureSEC source: 0001209191-23-048655 · doc4.xml · nonDerivative · entry 1 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 410,506 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · ownership.direct: The reported sale of 5,687 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022. Read SEC document |
| July 24, 2023 Filed Jul 25, 2023 20:33 UTC |
Llorca JesusEVP & CFO
|
SaleCommon Stock | 2,392 | $12.09 | $28,919.28 |
DisclosureSEC source: 0001209191-23-043312 · doc4.xml · nonDerivative · entry 2 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 416,193 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F4 · ownership.direct: The reported sale of 2,392 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022. Read SEC document |
| July 21, 2023 Filed Jul 25, 2023 20:33 UTC |
Llorca JesusEVP & CFO
|
SaleCommon Stock | 3,511 | $12.00 | $42,132.00 |
DisclosureSEC source: 0001209191-23-043312 · doc4.xml · nonDerivative · entry 1 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 418,585 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · ownership.direct: The reported sale of 3,511 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022. Read SEC document |
| July 19, 2023 Filed Jul 20, 2023 20:42 UTC |
Llorca JesusEVP & CFO
|
SaleCommon Stock | 700 | $12.00 | $8,400.00 |
DisclosureSEC source: 0001209191-23-042907 · doc4.xml · nonDerivative · entry 2 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 422,096 F2 · ownership.direct: The reported sale of 700 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022. Read SEC document |
| July 18, 2023 Filed Jul 20, 2023 20:42 UTC |
Llorca JesusEVP & CFO
|
SaleCommon Stock | 328 | $12.00 | $3,936.00 |
DisclosureSEC source: 0001209191-23-042907 · doc4.xml · nonDerivative · entry 1 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 422,796 F1 · ownership.direct: The reported sale of 328 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 21:22 UTC |
Llorca JesusEVP & CFO
|
SaleCommon Stock | 3,069 | $12.01 | $36,847.95 |
DisclosureSEC source: 0001209191-23-042466 · doc4.xml · nonDerivative · entry 1 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 423,124 F1 · ownership.direct: The reported sale of 3,069 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 20:28 UTC |
Miguel Bejos AlfredoDirector
|
Tax withholdingCommon Stock | 3,266 | $9.74 | $31,810.84 |
DisclosureSEC source: 0001209191-23-035399 · doc4.xml · nonDerivative · entry 2 Miguel Bejos Alfredo · CIK 0001777507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,119 Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 23:41 UTC |
Persily JulieDirector
|
GrantCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035244 · doc4.xml · nonDerivative · entry 1 Persily Julie · CIK 0001593007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,852 F1 · shares: The restricted stock award reported on this Form 4 will lapse on the earlier of (i) the date of the 2024 annual meeting of stockholders of the Issuer and (ii) June 6, 2024. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 23:39 UTC |
MORSE ANDREW RDirector
|
GrantCommon Stock | 20,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035242 · doc4.xml · nonDerivative · entry 1 MORSE ANDREW R · CIK 0001254946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,640 F1 · shares: The restricted stock award reported on this Form 4 will lapse on the earlier of (i) the date of the 2024 annual meeting of stockholders of the Issuer and (ii) June 6, 2024. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 23:37 UTC |
Regan Robert ChristopherDirector
|
GrantCommon Stock | 15,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035240 · doc4.xml · nonDerivative · entry 2 Regan Robert Christopher · CIK 0001338856 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,874 F2 · shares: The restricted stock award reported on this Form 4 will lapse on the earlier of (i) the date of the 2024 annual meeting of stockholders of the Issuer and (ii) June 6, 2024. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:28 UTC |
Miguel Bejos AlfredoDirector
|
GrantCommon Stock | 10,912 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035399 · doc4.xml · nonDerivative · entry 1 Miguel Bejos Alfredo · CIK 0001777507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,385 F1 · shares: The restricted stock award reported on this Form 4 will lapse on the earlier of (i) the date of the 2024 annual meeting of stockholders of the Issuer and (ii) June 6, 2024. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 23:37 UTC |
Regan Robert ChristopherDirector
|
SaleCommon Stock | 16,000 | $9.13 | $146,080.00 |
DisclosureSEC source: 0001209191-23-035240 · doc4.xml · nonDerivative · entry 1 Regan Robert Christopher · CIK 0001338856 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,022 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.94 to $9.29, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 21:42 UTC |
Rossmiller Gregory ScottSVP & CAO
|
Tax withholdingCommon Stock | 25,611 | $10.29 | $263,537.19 |
DisclosureSEC source: 0001209191-23-017541 · doc4.xml · nonDerivative · entry 2 Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,275 Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 21:44 UTC |
Regan Robert ChristopherDirector
|
SaleCommon Stock | 21,666 | $10.21 | $221,209.86 |
DisclosureSEC source: 0001209191-23-017544 · doc4.xml · nonDerivative · entry 1 Regan Robert Christopher · CIK 0001338856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,022 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 21:44 UTC |
Everett Andrew H IISr. VP, General Counsel & Secy
|
Tax withholdingCommon Stock | 26,741 | $10.29 | $275,164.89 |
DisclosureSEC source: 0001209191-23-017543 · doc4.xml · nonDerivative · entry 2 Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,322 Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 21:40 UTC |
Gellert John MDirector · President and CEO
|
Tax withholdingCommon Stock | 63,984 | $10.29 | $658,395.36 |
DisclosureSEC source: 0001209191-23-017539 · doc4.xml · nonDerivative · entry 3 Gellert John M · CIK 0001292966 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 759,150 Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 21:41 UTC |
Llorca JesusEVP & CFO
|
Tax withholdingCommon Stock | 64,194 | $10.29 | $660,556.26 |
DisclosureSEC source: 0001209191-23-017540 · doc4.xml · nonDerivative · entry 2 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,193 Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 21:42 UTC |
Rossmiller Gregory ScottSVP & CAO
|
GrantPerformance Restricted Stock Units · Derivative | 18,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017541 · doc4.xml · derivative · entry 3 Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,595 Underlying: Common Stock · 18,595 shares Expires not disclosed F2 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements. F3 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $11.61, $13.21, $14.91, $16.62 and $18.22, respectively. F3 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $11.61, $13.21, $14.91, $16.62 and $18.22, respectively. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 21:42 UTC |
Rossmiller Gregory ScottSVP & CAO
|
GrantCommon Stock | 56,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017541 · doc4.xml · nonDerivative · entry 1 Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,886 F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2024 and ending on March 4, 2026. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 21:44 UTC |
Everett Andrew H IISr. VP, General Counsel & Secy
|
GrantPerformance Restricted Stock Units · Derivative | 19,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017543 · doc4.xml · derivative · entry 3 Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,920 Underlying: Common Stock · 19,920 shares Expires not disclosed F2 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements. F3 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $11.61, $13.21, $14.91, $16.62 and $18.22, respectively. F3 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $11.61, $13.21, $14.91, $16.62 and $18.22, respectively. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 21:44 UTC |
Everett Andrew H IISr. VP, General Counsel & Secy
|
GrantCommon Stock | 60,978 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017543 · doc4.xml · nonDerivative · entry 1 Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,063 F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2024 and ending on March 4, 2026. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 21:40 UTC |
Gellert John MDirector · President and CEO
|
GrantPerformance Restricted Stock Units · Derivative | 47,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017539 · doc4.xml · derivative · entry 8 Gellert John M · CIK 0001292966 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,810 Underlying: Common Stock · 47,810 shares Expires not disclosed F6 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements. F7 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $11.61, $13.21, $14.91, $16.62 and $18.22, respectively. F7 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $11.61, $13.21, $14.91, $16.62 and $18.22, respectively. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 21:40 UTC |
Gellert John MDirector · President and CEO
|
GrantCommon Stock | 146,343 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017539 · doc4.xml · nonDerivative · entry 2 Gellert John M · CIK 0001292966 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 823,134 F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2024 and ending on March 4, 2026. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 21:41 UTC |
Llorca JesusEVP & CFO
|
GrantPerformance Restricted Stock Units · Derivative | 38,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017540 · doc4.xml · derivative · entry 3 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,515 Underlying: Common Stock · 38,515 shares Expires not disclosed F2 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements. F3 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $11.61, $13.21, $14.91, $16.62 and $18.22, respectively. F3 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $11.61, $13.21, $14.91, $16.62 and $18.22, respectively. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 21:41 UTC |
Llorca JesusEVP & CFO
|
GrantCommon Stock | 117,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017540 · doc4.xml · nonDerivative · entry 1 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,387 F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2024 and ending on March 4, 2026. Read SEC document |
| March 07, 2023 Filed Feb 13, 2024 23:44 UTC |
Gellert John MDirector · President and CEO
|
GiftCommon Stock | 12,634 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-014785 · ownership.xml · nonDerivative · entry 2 Gellert John M · CIK 0001292966 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · MCG Assets, LLC Disclosed balance after: 0 F2 · kind: On 3/7/23, MCG Assets, LLC contributed 12,634 shares to a grantor retained annuity trust ("GRAT"). The GRAT has an independent trustee and the Reporting Person has no investment control thereof. Accordingly, shares owned by the GRAT are not reported by the Reporting Person. The terms of the GRAT provide for two annual annuity payments to MCG Assets, LLC and, upon expiration of the GRAT, the Reporting Person is a co-beneficiary of the remainder (if any) of the GRAT. F1 · ownership.nature: The Reporting Person serves as a manager of MCG Assets, LLC and, as such, has the power to direct the voting and disposition of the reported securities. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest in the reported securities. Read SEC document |
| March 01, 2023 Filed Feb 13, 2024 23:44 UTC |
Gellert John MDirector · President and CEO
|
GiftCommon Stock | 4,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-014785 · ownership.xml · nonDerivative · entry 1 Gellert John M · CIK 0001292966 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · MCG Assets, LLC Disclosed balance after: 12,634 F1 · ownership.nature: The Reporting Person serves as a manager of MCG Assets, LLC and, as such, has the power to direct the voting and disposition of the reported securities. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest in the reported securities. Read SEC document |
| February 23, 2023 Filed Mar 9, 2023 21:40 UTC |
Gellert John MDirector · President and CEO
|
GiftCommon Stock | 8,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017539 · doc4.xml · nonDerivative · entry 4 Gellert John M · CIK 0001292966 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · MCG Assets, LLC Disclosed balance after: 8,534 F2 · ownership.nature: The Reporting Person serves as the manager of MCG Assets, LLC and, as such, has the power to direct the voting and disposition of the reported securities. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest in the securities. Read SEC document |
| February 23, 2023 Filed Mar 9, 2023 21:40 UTC |
Gellert John MDirector · President and CEO
|
GiftCommon Stock | 6,234 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017539 · doc4.xml · nonDerivative · entry 1 Gellert John M · CIK 0001292966 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 676,791 Read SEC document |
| June 09, 2022 Filed Jun 9, 2022 21:56 UTC |
Miguel Bejos AlfredoDirector
|
GrantCommon Stock | 10,885 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035547 · doc4.xml · nonDerivative · entry 2 Miguel Bejos Alfredo · CIK 0001777507 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,473 F1 · shares: The restricted stock award reported on this Form 4 will lapse on June 7, 2023. Read SEC document |
| June 09, 2022 Filed Jun 9, 2022 21:57 UTC |
MORSE ANDREW RDirector
|
GrantCommon Stock | 20,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035553 · doc4.xml · nonDerivative · entry 1 MORSE ANDREW R · CIK 0001254946 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,466 F1 · shares: The restricted stock award reported on this Form 4 will lapse on June 7, 2023. Read SEC document |
| June 09, 2022 Filed Jun 9, 2022 21:53 UTC |
Persily JulieDirector
|
GrantCommon Stock | 13,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035542 · doc4.xml · nonDerivative · entry 1 Persily Julie · CIK 0001593007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,852 F1 · shares: The restricted stock award reported on this Form 4 will lapse on June 7, 2023. Read SEC document |
| June 09, 2022 Filed Jun 9, 2022 21:52 UTC |
Regan Robert ChristopherDirector
|
GrantCommon Stock | 15,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035537 · doc4.xml · nonDerivative · entry 1 Regan Robert Christopher · CIK 0001338856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,688 F1 · shares: The restricted stock award reported on this Form 4 will lapse on June 7, 2023. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 21:56 UTC |
Miguel Bejos AlfredoDirector
|
Tax withholdingCommon Stock | 6,500 | $9.18 | $59,670.00 |
DisclosureSEC source: 0001209191-22-035547 · doc4.xml · nonDerivative · entry 1 Miguel Bejos Alfredo · CIK 0001777507 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,588 Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 22:59 UTC |
Rossmiller Gregory ScottSVP & CAO
|
GrantPerformance Restricted Stock Units · Derivative | 20,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018968 · doc4.xml · derivative · entry 3 Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,080 Underlying: Common Stock · 20,080 shares Expires not disclosed F2 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements. F3 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $5.02, $5.72, $6.45, $7.19 and $7.88, respectively. F3 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $5.02, $5.72, $6.45, $7.19 and $7.88, respectively. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 22:59 UTC |
Rossmiller Gregory ScottSVP & CAO
|
GrantCommon Stock | 72,291 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018968 · doc4.xml · nonDerivative · entry 2 Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,973 F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2023 and ending on March 4, 2025. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 22:59 UTC |
Rossmiller Gregory ScottSVP & CAO
|
Tax withholdingCommon Stock | 9,840 | $5.88 | $57,859.20 |
DisclosureSEC source: 0001209191-22-018968 · doc4.xml · nonDerivative · entry 1 Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,682 Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 23:02 UTC |
Everett Andrew H IISr. VP, General Counsel & Secy
|
GrantPerformance Restricted Stock Units · Derivative | 20,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018970 · doc4.xml · derivative · entry 3 Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,080 Underlying: Common Stock · 20,080 shares Expires not disclosed F2 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements. F3 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $5.02, $5.72, $6.45, $7.19 and $7.88, respectively. F3 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $5.02, $5.72, $6.45, $7.19 and $7.88, respectively. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 23:02 UTC |
Everett Andrew H IISr. VP, General Counsel & Secy
|
GrantCommon Stock | 72,291 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018970 · doc4.xml · nonDerivative · entry 2 Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,085 F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2023 and ending on March 4, 2025. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 23:02 UTC |
Everett Andrew H IISr. VP, General Counsel & Secy
|
Tax withholdingCommon Stock | 13,305 | $5.88 | $78,233.40 |
DisclosureSEC source: 0001209191-22-018970 · doc4.xml · nonDerivative · entry 1 Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,794 Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 22:54 UTC |
Llorca JesusEVP & CFO
|
GrantPerformance Restricted Stock Units · Derivative | 45,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018967 · doc4.xml · derivative · entry 3 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,515 Underlying: Common Stock · 45,515 shares Expires not disclosed F2 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements. F3 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $5.02, $5.72, $6.45, $7.19 and $7.88, respectively. F3 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $5.02, $5.72, $6.45, $7.19 and $7.88, respectively. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 22:54 UTC |
Llorca JesusEVP & CFO
|
GrantCommon Stock | 163,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018967 · doc4.xml · nonDerivative · entry 2 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,499 F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2023 and ending on March 4, 2025. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 22:54 UTC |
Llorca JesusEVP & CFO
|
Tax withholdingCommon Stock | 38,214 | $5.88 | $224,698.32 |
DisclosureSEC source: 0001209191-22-018967 · doc4.xml · nonDerivative · entry 1 Llorca Jesus · CIK 0001705427 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,642 Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 23:04 UTC |
Gellert John MDirector · President and CEO
|
GrantPerformance Restricted Stock Units · Derivative | 58,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018971 · doc4.xml · derivative · entry 7 Gellert John M · CIK 0001292966 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,905 Underlying: Common Stock · 58,905 shares Expires not disclosed F5 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements. F6 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $5.02, $5.72, $6.45, $7.19 and $7.88, respectively. F6 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $5.02, $5.72, $6.45, $7.19 and $7.88, respectively. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.